Literature DB >> 26729835

Concurrent insulinoma and impaired glucose tolerance suspected as owing to obesity.

Katsumi Iizuka1, Taro Fujisawa1, Jun Takeda1.   

Abstract

An obese 68-year-old woman was admitted for examination of fasting hypoglycaemia. A prolonged 18 h fast reduced her plasma glucose without suppressing insulin secretion, while plasma β-hydroxybutyrate levels were suppressed. Despite the prolonged fast, the glucose response to glucagon was increased by 25 mg/dL (1.39 mM) glucose, which is compatible with insulinoma. A 75 g oral glucose tolerance test (75 g OGTT) showed impaired glucose tolerance. An abdominal CT scan revealed a mass lesion in the uncinate process of the pancreas, a finding consistent with the results of angiography and selective artery calcium injection test. The patient then underwent a pancreaticoduodenectomy; the pancreatic mass was histologically diagnosed as benign insulinoma. After surgery, a prolonged 24 h fast caused no hypoglycaemia and the glucose tolerance capacity in 75 g OGTT improved. Eight months after surgery, the patient's body weight had reduced by 10 kg. This is therefore a case of concurrent insulinoma and impaired glucose tolerance. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26729835      PMCID: PMC4716377          DOI: 10.1136/bcr-2015-213793

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  22 in total

1.  Defective glucose utilization in patients with functioning beta-cell tumors persists after tumor excision.

Authors:  G S McGee; M M Kulaylat; N N Abumrad
Journal:  Ann Surg       Date:  1987-10       Impact factor: 12.969

2.  [Insulinoma--a statistical review of 443 cases in Japan].

Authors:  H Ishii; T Ito; S Moriya; Y Horie; M Tsuchiya
Journal:  Nihon Rinsho       Date:  1993-01

3.  Glucose-responsive insulinoma in a patient with postprandial hypoglycemia in the morning.

Authors:  Keiji Iida; Takeshi Ohara; Yasuhisa Hino; Masahide Nobuhara; Jun Ishida; Kazuo Chihara
Journal:  Intern Med       Date:  2010-10-01       Impact factor: 1.271

4.  Insulin resistance in a case of coexisting insulinoma and type 2 diabetes.

Authors:  G Grunberger
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

5.  Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium.

Authors:  J L Doppman; R Chang; D L Fraker; J A Norton; H R Alexander; D L Miller; E Collier; M C Skarulis; P Gorden
Journal:  Ann Intern Med       Date:  1995-08-15       Impact factor: 25.391

6.  Abnormalities of proinsulin processing in functioning insulinomas: clinical implications.

Authors:  Peter Wiesli; Aurel Perren; Parvin Saremaslani; Thomas Pfammatter; Giatgen A Spinas; Christoph Schmid
Journal:  Clin Endocrinol (Oxf)       Date:  2004-10       Impact factor: 3.478

7.  Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis.

Authors:  Tetsuhide Ito; Hisato Igarashi; Kazuhiko Nakamura; Hironobu Sasano; Takuji Okusaka; Koji Takano; Izumi Komoto; Masao Tanaka; Masayuki Imamura; Robert T Jensen; Ryoichi Takayanagi; Akira Shimatsu
Journal:  J Gastroenterol       Date:  2014-02-06       Impact factor: 7.527

8.  Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience.

Authors:  Jean-Marc Guettier; Anthony Kam; Richard Chang; Monica C Skarulis; Craig Cochran; H Richard Alexander; Steven K Libutti; James F Pingpank; Phillip Gorden
Journal:  J Clin Endocrinol Metab       Date:  2009-02-03       Impact factor: 5.958

9.  Report of the committee on the classification and diagnostic criteria of diabetes mellitus.

Authors:  Yutaka Seino; Kishio Nanjo; Naoko Tajima; Takashi Kadowaki; Atsunori Kashiwagi; Eiichi Araki; Chikako Ito; Nobuya Inagaki; Yasuhiko Iwamoto; Masato Kasuga; Toshiaki Hanafusa; Masakazu Haneda; Kohjiro Ueki
Journal:  J Diabetes Investig       Date:  2010-10-19       Impact factor: 4.232

10.  Co-existence of insulinoma and diabetes: A case report.

Authors:  Zbigniew Krzysztof Kamocki; Natalia Anna Wodyńska; Anna Pryczynicz
Journal:  Oncol Lett       Date:  2014-07-10       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.